Skip to main content
KBIO COMPANY Inc. logo

KBIO COMPANY Inc. — Investor Relations & Filings

Ticker · 038530 ISIN · KR7038530002 KO Manufacturing
Open in API
Filings indexed 440 across all filing types
Latest filing 2023-07-24 Share Issue/Capital Cha…
Country KR South Korea
Listing KO 038530

About KBIO COMPANY Inc.

https://kbio.com/

KBio specializes in plant-based manufacturing of biologics. The company utilizes its proprietary RP3 platform, which leverages plants as biofoundries for the efficient and sustainable production of high-quality proteins, therapeutics, and other bioactive compounds. This innovative approach is designed to surpass traditional manufacturing limitations, enabling the rapid development and large-scale production of biomolecules. The company's focus includes developing novel product candidates such as antibody therapies to address public health challenges and areas of high unmet medical need.

Recent filings

Filing Released Lang Actions
전환가액의조정
Share Issue/Capital Change Classification · 100% confidence The document is a formal regulatory filing from a South Korean company (K-Bio) regarding the 'Adjustment of Conversion Price' for convertible bonds (CB). This type of filing is a standard corporate disclosure related to capital structure changes and financing terms. In the context of the provided categories, it falls under 'Capital/Financing Update' (CAP) as it details the adjustment of conversion prices and the resulting change in the number of convertible shares, which directly impacts the company's capital structure.
2023-07-24 Korean
주권매매거래정지해제(감자 주권 변경상장)
Delisting Announcement Classification · 100% confidence The document is a short regulatory notice regarding the lifting of a trading suspension for K-Bio Company due to a capital reduction (reverse stock split/change in shares). It is a brief, official announcement from a stock exchange (KOSDAQ) rather than a comprehensive financial report or a specific corporate action like a dividend or director dealing. Since it does not fit into the other specific categories, it is classified as a general regulatory filing.
2023-07-18 Korean
감자완료
Share Issue/Capital Change Classification · 100% confidence The document is a formal announcement regarding the completion of a capital reduction (감자완료) by the company K-Bio. It details the specific changes to capital, par value, and the effective date of the reduction. This falls under the category of capital structure changes, which is classified as 'Share Issue/Capital Change' (SHA) in the provided schema, as it pertains to changes in the company's capital structure and share-related metrics.
2023-07-10 Korean
주권매매거래정지(주식의 병합, 분할 등 전자등록 변경, 말소)
Delisting Announcement Classification · 100% confidence The document is a short regulatory notice regarding the suspension of stock trading for (주)케이바이오컴퍼니 due to capital reduction and stock consolidation. It is a specific regulatory announcement issued by the exchange, not a full report, and fits best under the general regulatory filings category as it pertains to market operations.
2023-06-27 Korean
기타시장안내(상장적격성 실질심사 대상 제외 결정)
Delisting Announcement Classification · 100% confidence The document is a short regulatory announcement from the Korea Exchange regarding the decision to exclude a company (K-Bio Company, formerly Gold Pacific) from the 'substantive review of listing eligibility' process. It is a regulatory notice concerning trading resumption and listing status, which fits the 'Regulatory Filings' (RNS) category as it is a specific market announcement that does not fall into the other specialized categories like M&A, dividends, or financial reports.
2023-06-14 Korean
주권매매거래정지해제(상장적격성 실질심사 대상 제외 결정)
Delisting Announcement Classification · 100% confidence The document is a short regulatory notice regarding the lifting of a trading suspension for a specific stock (Gold Pacific). It cites KOSDAQ market regulations and provides the effective date for the resumption of trading. Since it is a regulatory announcement regarding market status rather than a financial report, dividend, or corporate action, it falls under the general regulatory filings category.
2023-06-14 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.